These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 37508209)

  • 1. Heteroresistance to Colistin in Clinical Isolates of
    Sánchez-León I; García-Martínez T; Diene SM; Pérez-Nadales E; Martínez-Martínez L; Rolain JM
    Antibiotics (Basel); 2023 Jun; 12(7):. PubMed ID: 37508209
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Insight into Antibiotic Synergy Combinations for Eliminating Colistin Heteroresistant
    Rajakani SG; Xavier BB; Sey A; Mariem EB; Lammens C; Goossens H; Glupczynski Y; Malhotra-Kumar S
    Genes (Basel); 2023 Jul; 14(7):. PubMed ID: 37510330
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical and Genomic Characterization of Carbapenem-Resistant
    Cerón S; Salem-Bango Z; Contreras DA; Ranson EL; Yang S
    Microorganisms; 2023 Jun; 11(7):. PubMed ID: 37512889
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ceftazidime-Avibactam Treatment for
    Marino A; Pulvirenti S; Campanella E; Stracquadanio S; Ceccarelli M; Micali C; Tina LG; Di Dio G; Stefani S; Cacopardo B; Nunnari G
    Antibiotics (Basel); 2023 Jul; 12(7):. PubMed ID: 37508265
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Emergence of Carbapenem-Resistant Gram-Negative Isolates in Hospital Settings in Djibouti.
    Ragueh AA; Aboubaker MH; Mohamed SI; Rolain JM; Diene SM
    Antibiotics (Basel); 2023 Jun; 12(7):. PubMed ID: 37508230
    [No Abstract]   [Full Text] [Related]  

  • 6.
    Hamed SM; Elkhatib WF; Brangsch H; Gesraha AS; Moustafa S; Khater DF; Pletz MW; Sprague LD; Neubauer H; Wareth G
    Antibiotics (Basel); 2023 Jul; 12(7):. PubMed ID: 37508245
    [No Abstract]   [Full Text] [Related]  

  • 7. Fluorescence Microscopy: Determination of Meropenem Activity against
    Alieva KN; Golikova MV; Kuznetsova AA; Zinner SH
    Antibiotics (Basel); 2023 Jul; 12(7):. PubMed ID: 37508266
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In Vitro Activity of Cefiderocol against a Global Collection of Carbapenem-Resistant
    Seifert H; Müller C; Stefanik D; Higgins PG; Wohlfarth E; Kresken M
    Antibiotics (Basel); 2023 Jul; 12(7):. PubMed ID: 37508268
    [No Abstract]   [Full Text] [Related]  

  • 9. Colistin resistance mutations in phoQ can sensitize Klebsiella pneumoniae to IgM-mediated complement killing.
    van der Lans SPA; Janet-Maitre M; Masson FM; Walker KA; Doorduijn DJ; Janssen AB; van Schaik W; Attrée I; Rooijakkers SHM; Bardoel BW
    Sci Rep; 2023 Aug; 13(1):12618. PubMed ID: 37537263
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of Antimicrobial Susceptibility in Bacterial Pathogens Associated with Urinary Tract Infections from Beijing Teaching Hospital in China, 2009-2017.
    Xie Z; Jian J; Chen L
    Can J Infect Dis Med Microbiol; 2023; 2023():4360342. PubMed ID: 37529141
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular Characterization of Antibiotic Resistance Determinants in
    Okafor JU; Nwodo UU
    Antibiotics (Basel); 2023 Jul; 12(7):. PubMed ID: 37508235
    [No Abstract]   [Full Text] [Related]  

  • 12. Insights into the Intersection of Biocide Resistance, Efflux Pumps, and Sequence Types in Carbapenem-Resistant
    Taj Z; Rasool MH; Khurshid M; Aslam B; Qamar MU
    Pathogens; 2023 Jun; 12(7):. PubMed ID: 37513746
    [No Abstract]   [Full Text] [Related]  

  • 13. Epidemiological characteristics of
    Zhu J; Ju Y; Zhou X; Chen T; Zhuge X; Dai J
    Front Microbiol; 2023; 14():1219733. PubMed ID: 37538843
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Similarity Analysis of
    Pruss A; Kwiatkowski P; Sienkiewicz M; Masiuk H; Łapińska A; Kot B; Kilczewska Z; Giedrys-Kalemba S; Dołęgowska B
    Antibiotics (Basel); 2023 Jul; 12(7):. PubMed ID: 37508320
    [No Abstract]   [Full Text] [Related]  

  • 15. Current Treatment Approach, Emerging Therapies and New Horizons in Systemic Lupus Erythematosus.
    Athanassiou P; Athanassiou L
    Life (Basel); 2023 Jul; 13(7):. PubMed ID: 37511872
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cyanocobalamin-Modified Colistin-Hyaluronan Conjugates: Synthesis and Bioactivity.
    Dubashynskaya NV; Bokatyi AN; Sall TS; Egorova TS; Nashchekina YA; Dubrovskii YA; Murashko EA; Vlasova EN; Demyanova EV; Skorik YA
    Int J Mol Sci; 2023 Jul; 24(14):. PubMed ID: 37511308
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Testing the mutant selection window hypothesis with meropenem: In vitro model study with OXA-48-producing Klebsiella pneumoniae.
    Alieva KN; Golikova MV; Dovzhenko SA; Kobrin MB; Strukova EN; Ageevets VA; Avdeeva AA; Sulian OS; Sidorenko SV; Zinner SH
    PLoS One; 2023; 18(8):e0288660. PubMed ID: 37540701
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of the Ability to Form Biofilms in KPC-Producing and ESBL-Producing
    Sabença C; Costa E; Sousa S; Barros L; Oliveira A; Ramos S; Igrejas G; Torres C; Poeta P
    Antibiotics (Basel); 2023 Jul; 12(7):. PubMed ID: 37508239
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro development of imipenem/relebactam resistance in KPC-producing Klebsiella pneumoniae involves multiple mutations including OmpK36 disruption and KPC modification.
    Gato E; Guijarro-Sánchez P; Alonso-García I; Pedraza-Merino R; Conde A; Lence E; Rumbo-Feal S; Peña-Escolano A; Lasarte-Monterrubio C; Blanco-Martín T; Fernández-González A; Fernández-López MDC; Maceiras R; Martínez-Guitián M; Vázquez-Ucha JC; Martínez-Martínez L; González-Bello C; Arca-Suárez J; Beceiro A; Bou G
    Int J Antimicrob Agents; 2023 Oct; 62(4):106935. PubMed ID: 37541530
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mobile Colistin Resistance (
    Anyanwu MU; Jaja IF; Okpala COR; Njoga EO; Okafor NA; Oguttu JW
    Antibiotics (Basel); 2023 Jun; 12(7):. PubMed ID: 37508213
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.